Recommendation
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9289427/PubMed Central (PMC)Dostarlimab, a boon or a healthcare burden- too early to acertain ...The cost of each dose of the drug is $11,000 (Rs. 8,54,119/-) € 19355 (Rs 16,07,316/-) and Rs. 3.4 lakh/vial in India. Is this amount affordable by all members ...
- https://pubmed.ncbi.nlm.nih.gov/36330672/PubMedDostarlimab for recurrent mismatch repair-deficient endometrial ...Although the agent is substantially more costly, dostarlimab became cost-effective when its cost was reduced to $5489 per cycle. Keywords: cost-effectiveness; ...
- https://en.wikipedia.org/wiki/DostarlimabDostarlimab - WikipediaDostarlimab, sold under the brand name Jemperli, is a monoclonal antibody used as an anti-cancer medication for the treatment of endometrial cancer.
- https://everyone.org/jemperli-dostarlimabBuy Jemperli (dostarlimab) Online • Price & Costs | Everyone.orgJemperli (dostarlimab) is a programmed death receptor-1 (PD-1)-blocking antibody, for use in: It is available in vial form for intravenous infusion, containing ...
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1391896/fullCost-effectiveness of dostarlimab plus chemotherapy for ... - FrontiersJun 20, 2024 ... Dostarlimab in combination with chemotherapy was cost-effective for primary advanced or recurrent dMMR EC from the perspective of a United States payer.
- https://www.ndtv.com/science/10-points-on-dostarlimab-the-drug-that-cured-cancer-during-trials-3049609www.ndtv.com10 Points On Dostarlimab, The Drug That 'Cured' Cancer During TrialsJun 8, 2022 ... According to New York Times, the medicine costs nearly $11,000 or Rs 8.55 lakh per dose. Dostarlimab works by "unmasking" cancer cells, which in ...
- https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1111/1471-0528.17338Obstetrics and GynecologyDostarlimab for recurrent mismatch repair‐deficient endometrial ...Nov 4, 2022 ... In one-way sensitivity analyses, dostarlimab was cost-effective when its cost was reduced to $4905 (52% reduction). These results were robust in ...
- https://canjhealthtechnol.ca/index.php/cjht/article/view/PC0263/901View of Dostarlimab (Jemperli) | Canadian Journal of Health ...Treatment with Jemperli is expected to cost approximately $13,655 per patient every 28 days. Recommendation. The CADTH pCODR Expert Review Committee (pERC) ...
- https://english.zorginstituutnederland.nl/publications/reports/2024/07/10/package-advice-dostarlimab-jemperliAdvice - reimburse dostarlimab (Jemperli®) for the treatment of ...Jul 10, 2024 ... ... price arrangements for similar medicinal products. It is expected that dostarlimab will also be used for other conditions and that the costs ...
- https://www.ncpe.ie/wp-content/uploads/2022/12/Technical-Summary-Dostarlimab-HTA-ID-21045.docx.pdf1 Cost-effectiveness of dostarlimab (Jemperli®) monotherapy for the ...In June 2022, GlaxoSmithKline (Ireland) Ltd submitted a dossier examining the clinical effectiveness, cost-effectiveness and budget impact of dostarlimab ...
Recommend
All Categories
Others
Privacy Policy
Terms of Use
We scour the internet for answers to just about everything - from finding the latest kitchenware to finding
the best travel destinations.
A unique Q&A structure provides you with relevant information in a quick-read, easy-to-use format. With the
most common questions answered in this format, you're sure to find what you're looking for.
Copyright © 2024 Seahia. All rights reserved